Checkpoint Therapeutics, Inc.
CKPT · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | -10,826.8% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | -16,275.6% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | -16,268.3% |
| EPS Diluted | -18.74 | -0.7 | -0.23 | -0.18 |
| % Growth | -2,577.1% | -204.3% | -27.8% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |